🔎 Trials Near Me

Akèy › Limfom › Kalifòni › Baldwin Park

Etid klinik pou Limfom nan Baldwin Park, CA

21 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Ap rekriteFaz 2
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07583810

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Ap rekriteFaz 2
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07221500

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Ap rekriteFaz 1/2
  • Research Site, Duarte · 4 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06137144

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Ap rekriteFaz 3
  • City of Hope Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06084936

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Ap rekriteFaz 1/2
  • City of Hope National Medical Center, Duarte · 4 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT04588922

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06678659

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06528301

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Ap rekriteFaz 1/2
  • Dren Investigational Site, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Ap rekriteFaz 2
  • City of Hope National Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06915246

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT04830137

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Ap rekriteFaz 1
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT05371132

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • City of Hope, Duarte · 4 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • City of Hope Medical Foundation, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT04234048

Etid Limfom nan lòt vil

Lòt etid nan Baldwin Park

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.